“Regulatory risks are waning in the sector,†says Abhishek Sharma, pharma analyst at IIFL. Hereon, things are expected to move in positive direction for companies.
first published: Jul 11, 2016 09:04 am
A collection of the most-viewed Moneycontrol videos.
Gold ETFs vs Silver ETFs | Which One Is Your Wealth Buddy?
Nifty Sees Triple-Digit Cut Despite Strong Q2 From SBI & M&M; All Sectors In Red | Closing Bell Live
Groww's Rs 6,632 Cr IPO Opens For Subscription | Management On Future Path | IPO Watch Live
Realty, PSU Banks Lead Nifty Back Near 25,800; Shriram Finance Scales Record High| Closing Bell Live
